Word

RXMAPPER

Status

Pending

Status Code

730

Status Date

Tuesday, March 5, 2024

Serial Number

97414158

Mark Type

4000

Filing Date

Tuesday, May 17, 2022

Published for Opposition

Tuesday, July 11, 2023

Trademark Owner History

RxMapper, LLC - Owner At Publication

Classifications

9 Downloadable computer software for the structural and functional analysis of genomes for medical and pharmaceutical consultation, advice, and analysis; Downloadable mobile software for the structural and functional analysis of genomes for medical and pharmaceutical consultation, advice, and analysis; Downloadable computer software for the structural and functional analysis of genomes for pharmaceutical drug utilization consultation, advice, and analysis; Downloadable mobile software for the structural and functional analysis of genomes for pharmaceutical drug utilization consultation, advice, and analysis; Downloadable computer applications for retrieving and displaying health information; Downloadable mobile applications for retrieving and displaying health information; Downloadable computer software creating a database in the field of pharmaceutical drug and drug utilization information and featuring inputting and collection of data and information all for medical treatment and diagnostic purposes; Downloadable computer software for pharmaceutical cost management; Downloadable mobile software for analysis of pharmaceutical cost management; Downloadable computer software for the structural and functional analysis of genomes; Downloadable computer software for analysis of DNA and RNA sequencing for medical purposes

35 Pharmaceutical cost management services and drug utilization review services; Business consulting, business management, and business cost analysis of medical diagnosis, medical treatment, pharmaceutical cost management and drug utilization; Providing pharmaceutical cost management information via a website

44 Medical services; Telemedicine services; Clinical medical consultation services; Medical and pharmaceutical consultation, advice, and medical analysis services for the diagnosis of conditions and diseases for genomic maladies; Medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by non-genomic health care physicians and health care professionals for the diagnosis and treatment of diseases and conditions; genetic analysis services, namely, DNA and RNA sequencing for medical purposes; Pharmaceutical advice services; Medical advice services; Pharmaceutical drug advice; Pharmaceutical drug utilization advice; Providing health information; Providing pharmaceutical drug utilization information via a website; Health care services, namely, providing health care information services, namely, providing a database featuring information in the field of genetic analysis, pharmaceutical drug, and drug utilization; providing health care information services, namely, providing a database featuring information of data and information all for medical treatment and diagnostic purposes; Health assessment services, namely medical diagnosis and medical treatment services of conditions and diseases for genomic maladies; Health assessment services, namely, providing pharmaceutical drug and, drug utilization for diagnosis and treatment of conditions and diseases for genomic maladies; Genomic benefit management services, namely, medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by non-genomic health care physicians and health care professionals for the diagnosis and treatment of diseases and conditions; managed medical care and pharmaceutical consultation; Providing an Internet website portal featuring medical information in the fields of medicine and pharmaceuticals

42 Consulting services in the field of pharmaceutical research; Technical research in the field of pharmaceutical studies; Providing online non-downloadable software for the structural and functional analysis of genomes for medical and pharmaceutical consultation, advice, and analysis; Providing online non-downloadable computer software for the structural and functional analysis of genomes for medical and pharmaceutical consultation, advice, and analysis; providing online non-downloadable computer software for pharmaceutical drug utilization services; Providing online non-downloadable computer software for the structural and functional analysis of genomes for retrieving and displaying health information; Providing online non-downloadable computer software for the structural and functional analysis of genomes for use in health assessment services, namely, providing medical advice, pharmaceutical drug and drug utilization analysis services all for treatment and diagnostic purposes; providing online non-downloadable computer software for the structural and functional analysis of genomes for use in determining pharmaceutical cost management; Providing online non downloadable computer software for the structural and functional analysis of genomes; scientific research in the field of the structural and functional analysis of genomes; providing online non-downloadable computer software for DNA and RNA sequencing for medical purposes; providing online non-downloadable computer software for DNA and RNA analysis services for medical treatment purposes

Trademark Events

Mar 6, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 5, 2024

Sou Extension 1 Granted

Mar 5, 2024

Sou Extension 1 Filed

Mar 5, 2024

Sou Teas Extension Received

Sep 5, 2023

Noa E-Mailed - Sou Required From Applicant

Jul 11, 2023

Official Gazette Publication Confirmation E-Mailed

Jul 11, 2023

Published For Opposition

Jun 21, 2023

Notification Of Notice Of Publication E-Mailed

Jun 2, 2023

Approved For Pub - Principal Register

Jun 1, 2023

Teas/Email Correspondence Entered

Jun 1, 2023

Correspondence Received In Law Office

Jun 1, 2023

Teas Response To Office Action Received

Mar 7, 2023

Notification Of Non-Final Action E-Mailed

Mar 7, 2023

Non-Final Action E-Mailed

Mar 7, 2023

Non-Final Action Written

Mar 6, 2023

Assigned To Examiner

May 23, 2022

New Application Office Supplied Data Entered

May 20, 2022

New Application Entered